Latest

• Cefpodoxime proxetil – new opportunities in antibacterial therapy of respiratory infections

  Clinical Microbiology and Antimicrobial Chemotherapy. 2023; 25(4):366-371

• Official statements of the expert meeting on pneumococcal vaccination in adults in Russia

  Clinical Microbiology and Antimicrobial Chemotherapy. 2021; 23(2):161-165

• COVID19 pandemic is a «pandemic» of antimicrobial therapy

  Clinical Microbiology and Antimicrobial Chemotherapy. 2021; 23(1):5-15

• Potential for the use of macrolides in the antimicrobial therapy of severe community-acquired pneumonia in adults

  Clinical Microbiology and Antimicrobial Chemotherapy. 2019; 21(3):217-223

• Antibiotics and community-acquired lower respiratory tract infections. To whom? Which one?

  Clinical Microbiology and Antimicrobial Chemotherapy. 2019; 21(1):27-38

• Vaccination against pneumococcal infections in adults

  Clinical Microbiology and Antimicrobial Chemotherapy. 2018; 20(1):5-8

• Clinical Guidelines on Diagnosis, Treatment and Prophylaxis of Severe Community-Acquired Pneumonia in Adults

  Clinical Microbiology and Antimicrobial Chemotherapy. 2015; 17(2):84-126

• Short Courses of Antimicrobial Therapy: a New Treatment Paradigm for Community-Acquired Pneumonia?

  Clinical Microbiology and Antimicrobial Chemotherapy. 2013; 15(2):86-94

• Levofloxacin in the Treatment of Community-Acquired Pneumonia: 20-Year Successful Clinical Experience

  Clinical Microbiology and Antimicrobial Chemotherapy. 2013; 15(1):35-46

• The Management of Lower Respiratory Tract Infections in Adult Patients (Review of the 2011 ERS and ESCMID guidelines)

  Clinical Microbiology and Antimicrobial Chemotherapy. 2012; 14(1):4-16

• Modern Assessment Scores for Severe Community-Acquired Pneumonia: Perspectives and Limitations

  Clinical Microbiology and Antimicrobial Chemotherapy. 2011; 13(3):204-213

• Prevention of Legionellosis as a Basis for the New Approach to Prophylaxis of Hospital-Acquired Infections

  Clinical Microbiology and Antimicrobial Chemotherapy. 2010; 12(4):272-283

• Community-Acquired Pneumonia in Adults: Guidelines on the Diagnosis, Treatment and Prevention

  Clinical Microbiology and Antimicrobial Chemotherapy. 2010; 12(3):186-125

• Guidelines on Diagnosis and Treatment of Legionella pneumophila Serogroup 1 Infection

  Clinical Microbiology and Antimicrobial Chemotherapy. 2009; 11(1):4-13

• Current Guidelines for the Management of Adults with Community-Acquired Pneumonia: Way to a Single Standard

  Clinical Microbiology and Antimicrobial Chemotherapy. 2008; 10(4):305-321

• The Role of Chlamydophila pneumoniae in the Human Bronchopulmonary Diseases

  Clinical Microbiology and Antimicrobial Chemotherapy. 2008; 10(1):24-33

• Patient Compliance with Antimicrobial Therapy of Lower Respiratory Tract Infections

  Clinical Microbiology and Antimicrobial Chemotherapy. 2008; 10(1):15-23

• Asthma associated with Chlamydophila pneumoniae-infection

  Clinical Microbiology and Antimicrobial Chemotherapy. 2007; 9(3):233-243

• Legionellosis: the Role in Human Infectious Diseases

  Clinical Microbiology and Antimicrobial Chemotherapy. 2007; 9(3):219-232

• Efficacy and Safety of Josamycin in the Treatment of Mild-to-Moderate Community-Acquired Pneumonia: Results of Multicenter Clinical Study

  Clinical Microbiology and Antimicrobial Chemotherapy. 2007; 9(1):48-56

• Pneumonia in Nursing Homes: Current View on Problem

  Clinical Microbiology and Antimicrobial Chemotherapy. 2007; 9(1):4-19

• New oral formulation for the Treatment of Community-Acquired Lower Respiratory Tract Infections

  Clinical Microbiology and Antimicrobial Chemotherapy. 2006; 8(4):350-358

• Gemifloxacin in the Treatment of Community-Acquired Lower Respiratory Tract Infections

  Clinical Microbiology and Antimicrobial Chemotherapy. 2006; 8(3):260-269

• Lower Respiratory Tract Infections in Adult Patients: Diagnosis, Antimicrobial Therapy and Prophylaxis (According to the Guidelines of European Respiratory Society and European Society of Clinical Microbiology and Infectious Diseases)

  Clinical Microbiology and Antimicrobial Chemotherapy. 2006; 8(3):206-216

• Community-Acquired Pneumonia in Adults: Guidelines on Diagnosis, Treatment and Prophylaxis

  Clinical Microbiology and Antimicrobial Chemotherapy. 2006; 8(1):54-86

• Severe Acute Respiratory Syndrome: New Pieces of Puzzle

  Clinical Microbiology and Antimicrobial Chemotherapy. 2004; 6(2):108-123

• Severe Acute Respiratory Syndrome (SARS)

  Clinical Microbiology and Antimicrobial Chemotherapy. 2003; 5(3):225-242

• Community – Acquired Pneumonia: Giudelines on Diagnosis, Treatment and Prophylaxis

  Clinical Microbiology and Antimicrobial Chemotherapy. 2003; 5(3):198-224

• Antimicrobial Resistance of Streptococcus Pneumoniae in Different Regions of Russia: Results of Prospective Multicentre Study (phase А of project PeHAS-I)

  Clinical Microbiology and Antimicrobial Chemotherapy. 2002; 4(3):267-277

• New Guidelines on Management of Community Acquired Pnevmonia in Adults: Diagnostic, Evaluation of Severity, Antimicrobial Therapy, Prophylaxis

  Clinical Microbiology and Antimicrobial Chemotherapy. 2001; 3(4):355-370

• Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults

  Clinical Microbiology and Antimicrobial Chemotherapy. 2001; 3(1):54-68

• Legionellosis: the Role In Human Infectious Pathologies

  Clinical Microbiology and Antimicrobial Chemotherapy. 2001; 3(1):4-16

• Pilot Study of LongSterm Azithromycin Prophylaxis of Acute Bacterial Infections of Respiratory Tract in Military Persons

  Clinical Microbiology and Antimicrobial Chemotherapy. 2000; 2(1):31-36